Table 4.
Therapeutic and evolutional characteristics of patients.
| Parameters | Number (%) n = 63 |
|---|---|
| Type of therapy | |
| CHOP | 63 (100) |
| RCHOP | 0 (0) |
| Therapeutic response | |
| Complete remission | 27 (43) |
| Partial remission | 25 (40) |
| Failure | 11 (17) |
| Dose adherence | |
| Normal | 61 (97) |
| Reduction | 2 (3) |
| Delay of chemotherapy (days) | |
| <15 | 44 (70) |
| 15–30 | 14 (22) |
| >30 | 5 (8) |
| Treatment compliance | |
| Good | 27 (43) |
| Poor | 36 (57) |
| Toxicity | |
| Hematological | 23 (37) |
| Metabolic | 20 (32) |
| Digestive | 7 (11) |
| Cardiac | 3 (5) |
| Neuropathies | 3 (5) |
| Alopecia | 2 (3) |
| Number of cycles | |
| 4–7 | 46 (73) |
| >7 | 17 (27) |
| Outcome at median follow-up | |
| Progression-free survival | 20 (32) |
| Overall survival | 31 (49) |
| Lost to follow-up | 8 (13) |
| Dead | 32 (51) |
| Causes of death | |
| Progression | 17 (27) |
| Hematological toxicity | 7 (11) |
| Infection | 4 (6) |
| Metabolic toxicity | 2 (3) |
| Undetermined | 2 (3) |